低剂量纳曲酮治疗Hailey-Hailey病一例
Low-dose naltrexone: a novel treatment for Hailey-Hailey disease.
PubMed 文献 · Br J Dermatol · 2018-02-23
本文报告一例治疗抵抗的Hailey-Hailey病(慢性良性家族性天疱疮)患者,既往外用及口服糖皮质激素、预防性阿昔洛韦和多西环素以及氨苯砜、阿维A、环孢素等系统治疗均失败。
要点
- Hailey-Hailey病为罕见遗传性皮肤病,典型表现为间擦部位糜烂,常由轻微创伤或应激诱发。
- 该例患者对多种外用、口服及系统治疗均抵抗。
研究设计与样本
- 单例病例报告,报告一例治疗抵抗的Hailey-Hailey病患者。
主要发现
- 患者既往外用及口服糖皮质激素、预防性阿昔洛韦和多西环素以及氨苯砜、阿维A和环孢素治疗均失败。
- 迄今临床和心理反应显著。
局限性
- 仅为单例病例报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hailey-Hailey disease (chronic benign familial pemphigus) is a rare inherited dermatosis typically characterized by erosions at intertriginous sites preceded by minor trauma or stress. We report a case of treatment-resistant Hailey-Hailey disease having failed topical and oral steroids, prophylactic aciclovir and doxycycline, and systemic therapies including dapsone, acitretin and ciclosporin. Low-dose naltrexone 4·5 mg once daily was commenced following an incidental benefit in this patient's similarly affected sister. The clinical and psychological response to date has been considerable.
来源:Br J Dermatol,查看原文。版权归原作者所有。
引用
- Campbell V, McGrath C, Corry A, et al. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Br J Dermatol. 2018. PMID: 28991360. doi:10.1111/bjd.16045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。